Monday, January 23, 2012

To bolus or not to bolus in DKA

IVF and insulin drip
I recently saw an adult patient with diabetic ketoacidosis.  She was treated with intravenous fluids and an insulin drip and admitted to the ICU. There was some questioning among the nursing staff about whether or not she needed to receive an insulin bolus first.  I decided to look for some literature to share with the nursing staff, as well as educate myself.  Here is what I found:

In children with diabetic ketoacidosis, an insulin bolus is NOT recommended.  It is one of the factors that has been linked to increased risk of cerebral edema.  Do not bolus insulin in kids with DKA.

In adults the guidelines are less clear.  A recent review in Annals of Internal Medicine says that either a bolus followed by drip can be given, (regular insulin at 0.1 U/kg IV bolus followed by 0.1 U/kg/hr as continuous IV infusion), or simply an infusion started.  Tintinalli recommends just starting insulin infusion at 0.1 U/kg/hr.

A few pearls:
1.  Always give fluids before anything else, while awaiting lab results.  The average adult with DKA has a water deficit of 5-10 L.
2.  Wait for potassium level before starting insulin.  Many patients with DKA have a profound potassium deficit, even though serum levels can initially be normal or even high.  This is because the acidosis drives potassium out of cells in exchange for hydrogen ions, falsely elevating the potassium level. If initial [K+] level is <3.3, give potassium-containing fluids BEFORE starting insulin.  Otherwise life-threatening hypokalemia can result.
3.  Bicarbonate therapy is controversial due to risk of worsening hypokalemia, worsening intracellular acidosis.  Bicarbonate should not be routinely given, but should be considered for severe acidosis (pH < 6.9).
4.  Remember to look for precipitants of DKA, and treat any underlying conditions.



References:
1.  Rosenbloom, AL.  The management of diabetic ketoacidosis in children.  Diabetes Therapy 2010. 1:103-120.
2. From Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 7th Ed. Tintinalli, JE, Ed, et al.  New York: McGraw Hill, 2011: p. 442-445.
3.  Wilson et al.  In clinic:  Diabetic ketoacidosis.  Annals Internal Medicine 2010.  152(1):ITC1-1.




The management of diabetic ketoacidosis in children.Source:Diabetes Therapy [1869-6953] Rosenbloom yr:2010 vol:1 iss:2 pg:103 -120

Sunday, January 15, 2012

Beta blocker overdose

Sinus bradycardia with HR of 50
A 70 yo female presents with lightheadedness and feeling "crummy."  She was started on metoprolol yesterday by her PCP for an elevated heart rate.  Initial vital signs reveal HR of 31, BP 121/85, RR of 15, and T 37.  She had been having intermittent burning substernal chest pain but denies any currently.  On physical exam she is awake and alert but looks pale and uncomfortable.  Pupils are PERRL, CV exam reveals bradycardia with regular rhythm, there is no respiratory distress, lungs are clear to auscultation bilaterally, abdomen is soft and nondistended, neuro exam is intact.  Skin is warm and dry.  EKG shows sinus bradycardia with T wave inversions in leads II, III, and aVF.

The differential for bradycardia is broad and includes vasovagal response, sick sinus syndrome, myocardia ischemia involving right coronary artery, atrioventricular block, increased intracranial pressure (seen with elevated BP in Cushing's reflex), hypokalemia, hypothermia, hypothyroidism, and medications (beta blockers, calcium channel blockers, digoxin, clonidine).  Bradycardia can also be a normal finding, often seen in well-conditioned athletes.

The key branch point for management of bradycardia is whether or not signs of adequate perfusion are present.  If the bradycardia is leading to hypoperfusion, according to ACLS guidelines, transcutaneous pacing should be initiated while reversible causes (H's and T's) are investigated.  If the bradycardia is not causing hemodynamic compromise, patients can be monitored and observed.

While transcutaneous pacing is being set up, atropine 0.5 mg IV push should be given (repeat for total dose of 3 mg).  Dopamine is a second-line agent for when atropine is not effective.  Dose is 2-10 mcg/kg/min infusion.  Epinephrine is a third-line agent, dose 2-10 mcg/min infusion.  If beta blocker overdose is suspected, glucagon 1-5 mg IV should be given.  If heart rate responds, a glucagon infusion should be started.

Pacer pads were placed on the patient, but because she was maintaing her blood pressure and mentating well, transcutaneous pacing was not required.  She was given a fluid bolus as well as atropine 0.5 mg IV x 2 doses without improvement.  Because beta blocker overdose was a consideration, she was given glucagon 3.5 mg IV.  Because of possible ischemic changes on EKG, an aspirin was administered and cardiology was consulted.

Tuesday, January 10, 2012

Causes of hypertensive emergency

Causes of hypertensive emergency

Hypertensive emergency is defined as BP > 220/140 in the presence of target-organ damage.  Most cases of hypertensive emergency occur in patients with essential hypertension who have inadequate treatment of their hypertension or have discontinued their medications.  However there are many other causes of hypertensive emergencies:

1.  Renal parenchymal disease--acute glomerulonephritis, chronic pyelonephritis, tubulointerstitial nephritis

2.  Renovascular disease--fibromuscular dysplasia, polyarteritis nodosa, atherosclerosis

3.  Systemic disorders affecting kidneys-SLE, other vasculidities

4.  Endocrine causes--pheochromocytoma, Cushing syndrome, primary hyperaldosteronism (Conn's syndrome when caused by adrenal adenoma)

5.  Drugs--cocaine, amphetamine, ephedrine, diet pills, cyclosporine, clonidine withdrawal, oral contraceptives,

6.  Drug interactions--Monamine oxidase inhibitors when combined with tricyclic antidepressants, antihistamines, or tyramine-containing foods

7.  Pregnancy-related--preeclampsia/eclampsia

8.  CNS causes--CNS trauma, subarachnoid hemorrhage, ischemic and hemorrhagic stroke, spinal cord disorders

9.  Cardiovascular causes--coarctation of the aorta, acute aortic dissection

Classic teaching is that hypertensive emergency should be managed with IV agents to lower blood pressure by 20% within a few hours.  However, Tintinalli recommends treatment for hypertensive emergency should be stratified by diagnosis.  For example, in acute aortic dissection, SBP should be lowered to 100-120 range to reduce shearing forces on the vasculature.  In intracranial hemorrhage, SBP goal is < 160 to reduce chance of rebleeding.  In acute ischemic stroke, however, some degree of HTN is appropriate (maintain cerebral perfusion), but if fibrinolysis is planned, target BP is >185/110.  In acute renal failure, blood pressure reduction by no more than 20% is advised.  In acute sympathic crisis (cocaine, amphetamines, etc.), benzodiazepines can be administered for symptom relief.

References:
1.  Riaz K et al.  Emedicine:  Hypertension Treatment & Management.  Available at http://emedicine.medscape.com/article/241381-overview.  Accessed Jan. 10, 2012.
2.   From Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 7th Ed. Tintinalli, JE, Ed, et al.  New York: McGraw Hill, 2011: p. 442-445.

Saturday, January 7, 2012

Neonatal sepsis

Question:  What antibiotics should be given for a newborn with suspected septic shock?

Ampicillin PLUS gentamicin OR cefotaxime (from Tintinalli)

The main organisms to be concerned about are gram-positives (mainly Group B strep, also Listeria) and gram-negatives (E. coli).  Ampicillin, an extended-spectrum penicillin, covers group B strep and Listeria, while gentamicin, an aminoglycoside, provides coverage for gram negative organisms.  If gram negative meningitis is suspected, cefotaxime is favored for its better CNS penetration.

More on neonatal sepsis:
In the critically ill neonate, the diagnosis of sepsis should always be considered.  In the ED setting, it is not always possible to distinguish the various causes of the neonate in distress--septic shock, cardiogenic shock from congenital heart disease, inborn errors of metabolism, etc.  Therefore empiric treatment for septic shock should be initiated in the critically ill newborn, as early treatment of sepsis has been shown to improve outcomes.

Early-onset sepsis
Early-onset sepsis (within first few days of life) is typically due to infection acquired from the mother, either transplacentally, transcervically, or via contact with microbe during passage through a colonized birth canal.  Organisms responsible for early-onset sepsis include:

1.  Group B Strep
2.  E. coli
3.  Coagulase negative staph
4.  Haemophilus influenzae
5.  Listeria monocytogenes


Risk factors for early-onset neonatal sepsis include maternal GBS colonization (though incidence of GBS infection has been reduced due to third-trimester screening programs), premature rupture of membranes, prolonged rupture of membranes, preterm rupture of membranes, chorioamnionitis, prematurity, and maternal UTI.

Workup for the neonate with suspected sepsis includes CBC with differential, blood cultures, CSF gram stain and culture, chest xray, urine studies, and possibly CRP or other infection markers.  Hemodynamic support should be provided with IV fluids and pressors, if indicated.  Antibiotics should be started empirically to cover for gram positive organisms (especially group B strep), and gram-negative organisms (namely E. coli).  For infants < 1 week of age, Tintinalli recommends ampicillin PLUS gentamicin OR cefotaxime.

A 2009 Cochrane review sought to compare the efficacy of different antibiotic regimens for neonatal sepsis, and found that there was no evidence to recommend one particular regimen over another.  This was largely due to small sample size (only 2 studies comparing treatment of sepsis in infants < 48 hours old).



Late-onset sepsis
Late-onset sepsis (between 4-90 days of life) is more likely due to organisms acquired from the caregiving environment (including hospital-acquired infections).  While pneumonia is more common in early-onset sepsis, meningitis and bacteremia are more common in late-onset sepsis.  Organisms include:

1.  Coagulase negative staph
2.  Staph aureus
3.  E. coli
4.  Klebsiella
5.  Pseudomonas
6.  Group B strep
7.  Strep pneumoniae

For infants age 1-4 weeks, Tintinalli recommends ampicillin PLUS cefotaxime/ceftiaxone.  This covers for gram positive and gram negative organisms.


References:
1.  From Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 7th Ed. Tintinalli, JE, Ed, et al.  New York: McGraw Hill, 2011: p. 74, 1012.


2.  Cochrane review.  Antibiotics regimens for suspected early neonatal sepsis.  Published online 21 Jan 2009. Available at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004495.pub2/abstract.  Accessed Jan 7. 2012.

Thursday, January 5, 2012

Diagnosis of meningitis

Figure 1: Neisseria meningitidis, often referred to as meningococcus

Diagnosis of meningitis in adults:  Sensitivity of physical exam

Meningitis is a difficult-to-diagnose disease with potentially devastating consequences.  Meningitis refers to inflammation (usually infectious) of the meninges, a layer of membranes that enclose the brain and spinal cord.  Meningitis can be caused by bacteria, viruses, and fungi.  Common causes of bacterial meningitis include Strep pneumoniae (most common bacterial cause), Hemophilus influenza, Staphylococcus aureusNeisseria meningitidis, and Mycobacterium tuberculosis.  Meningitis typically results from hematogenous spread of bacteria to seed the meninges.  However, it can also occur from direct extension from sinusitis or otitis media, following neurosurgery, skull fracture, or other trauma which create a portal of entry of organisms.  Without treatment bacterial meningitis is usually fatal, and even with treatment, the mortality rate is 25%.

Other causes of meningitis include viral (enterovirus, HSV), fungal (cryptococcus), and parasitic.  Aspetic meningitis refers to a category in which meningeal inflammation is present but no infectious organism is identified.  Most of these cases are likely viral, but partially treated bacterial meningitis can also masquerade as aseptic meningitis.

Because of its nonspecific signs and symptoms, meningitis is a notoriously difficult disease to diagnose.  Physical exam findings such as Kernig's signs, Brudzinski's signs, and nuchal rigidity can aid in the diagnosis, but lack sensitivity and specificity.

A 2002 study in Clinical Infectious Disease evaluated the sensitivity of these bedside tests.  297 patients with suspected meningitis were examined prior to undergoing lumbar puncture to evaluate for meningitis (defined as >6 WBCs/mL spinal fluid).  The researchers found that the sensitivities for Kernig's sign, Brudzinski's sign, and nuchal rigidity for meningitis were a dismal 5%, 5%, and 30%, respectively.  In the very small subset of patients with severe meningeal irritation (4 patients; defined as >1000 WBCs/mL spinal fluid), only nuchal rigidity, but not the other two signs, had diagnostic value with a sensitivity of 100%.  The conclusion of the study was that these bedside tests are "too insensitive to identify the majority of patients with meningitis in contemporary practice."

Why am I writing this post?  Because I recently had a patient with fever and a headache.  She had no neck stiffness and no nuchal rigidity on exam.  In my mind this put the diagnosis of meningitis lower on the differential, which led to a delay in her getting a lumbar puncture, which, as it turns out, showed she did in fact have meningitis.  Fortunately the the patient did well.  But it was an important learning case for me.  If the sensitivity of nuchal rigidity is only 30% as this study reports (similar data seen in other studies), clearly I should not have felt reassured by her lack of nuchal rigidity, any more than I would have determined that a patient with a negative psoas sign could not have appendicitis.

No single physical exam finding or historical feature can rule in, or rule out, the diagnosis of meningitis.  The gold standard for diagnosis, a lumbar puncture, is a test with costs both to patient and physician, and not every patient with fever and headache should get a lumbar puncture.  This would expose patients to unnecessary risks and discomfort and create a disaster of work flow in a busy ED.  Rather the entire picture needs to be taken into account to push one to do the lumbar puncture:  historical features, patient appearance and physical exam findings, input from family/friends, and ultimately physician "gestalt."  This is what makes our job as emergency physicians challenging, and yet fun.  There are no algorithms or easy formulas to apply to evasive diagnoses like meningitis.  Knowing what to do when is the part of the art of medicine, something we all are all perfecting in our practice.


References:
1.  Razonable, R, Cunha B.  Meningitis. Available at http://emedicine.medscape.com/article/232915-overview.  Accessed January 5, 2012.
2.  Thomas KE, Hasbun R, Jekel J, ad Quagliarella VJ.  The diagnositc accuracy of Kernig’s sign, Brudzinski’s sign, and nuchal rigidity in adults with suspected meningitis.  Clin Infect Dis 2002. 35:46-52.

Wednesday, December 28, 2011

Drugs to avoid in G6PD deficiency

Drugs to avoid in G6PD deficiency

Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency have diminished levels of a key enzyme, G6PD, which protects red blood cells against oxidative stress.  Therefore they should not be prescribed oxidative drugs, which can result in rapid hemolysis of their red blood cells.

Most patients with G6PD deficiency are asymptomatic, but they may have a history of neonatal jaundice, often requiring exchange transfusion, or a history of drug-induced hemolysis.

The following drugs should be avoided.  I have highlighted ones commonly prescribed from an ED setting.

1.  Nitrofurantoin
2.  Pyridium
3.  Sulfamethoxazole (i.e. component of TMP/SMX or Bactrim)
4.  Primaquine
5.  Dapsone
6.  Flutamide
7.  Methylene blue
8.  Sulfacetamide
9.  Nalidixic acid


[Frank JE.  Diagnosis and Management of G6PD Deficiency.  Am Fam Physician 2005:72(7):1277-1282.] 

Tuesday, December 27, 2011

Corneal ulcer versus corneal abrasion

I recently had a patient with what I thought was a huge corneal ulcer. According to the ophthalmologist who saw the patient, it was actually just a very large corneal abrasion. How do you distinguish a corneal ulcer from an abrasion? Quick review:

Corneal abrasion
A corneal abrasion occurs when the corneal epithelium is damaged from causes such as fingernail scratches, contact lens wear, and foreign objects. The epithelium is richly innervated so corneal abrasions are usually very painful, but onset of pain can be delayed several hours after injury. Symptoms include foreign body sensation, photophobia, and tearing. Vision is usually normal unless the abrasion is in the central visual axis or if there is associated iritis. Slit lamp exam with the cobalt blue light reveals fluorescein uptake in the region of the corneal defect. If the abrasion is > 24 hours old, cell and flare from iritis may be present. However, there is no infiltrate.

Figure 1.  Corneal abrasion

Treatment goals include relieving symptoms and preventing secondary infection. Cycloplegics relax the ciliary body and relieve pain from spasm.  Narcotic pain medicines may be required for analgesia. Do not prescribe topical anesthetics, as they inhibit corneal healing and inhibit the normal corneal protective reflex of blinking when something gets in the eye. Topical antibiotics should be prescribed--erythromycin ointment (for organic source), ciprofloxacin/ofloxacin/tobramycin for contact lens users to cover for pseudomonas.

Patients with very large corneal abrasions should have ophthalmology follow-up within 24 hours; others can follow-up within 48-72 hours.


Corneal ulcer
A corneal ulcer refers to infection of the various layers of the cornea. Corneal ulcers develop when a break of the corneal epithelium results in microbial access to the underlying corneal stroma. Breaks in the corneal epithelium can be caused by trauma, desquamation, or direct microbial invasion. Contact lens use is associated with increased risk of ulcers, particularly caused by Pseudomonas aeruginosa. S. pneumoniae is another common cause of corneal ulcers. Viruses and fungi are causes of corneal ulcers in the setting of immunosuppression.


Figure 2.  Corneal ulcer caused by herpes virus with dendritic lesions

Symptoms include redness, pain, foreign body sensation, photophobia, and blurry vision. Visual acuity may be decreased if the ulcer is in the central visual access or if uveal tract inflammation is present. Pupillary constriction and consensual photophobia may be present due to ciliary spasm. Examination of the corneal reveals a whitish infiltrate (WBCs in the corneal stroma) and sometimes heaped-up edges of the ulcer. On slit-lamp exam, cell and flare and occasionally hypoypon (WBCs in anterior chamber) may be present.

Corneal ulcers are an emergency and patients should be seen by ophthalmology the same day. Treatment includes antibiotic eye drops and cycloplegics. Corneal ulcers should not be patched because of risk of worsening ulceration and perforation


[From Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 7th Ed. Tintinalli, JE, Ed, et al. New York: McGraw Hill, 2011: 594-596]